Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Durability of the Mumps Antibody Response After the Third Dose of MMR Vaccine.

The Journal of infectious diseases - 18 Feb 2026

Sowers Sun B, Nguyen Huong Q, Masters Nina B, Mercader Sara, Colley Heather, McClure David L, Hickman Carole J, Marin Mona, Crooke Stephen N

Abstract excerpt

BACKGROUND: A third dose of measles, mumps, and rubella vaccine (MMR3) may be administered in outbreak and nonoutbreak settings. However, data on long-term immunogenicity to the mumps component of MMR are limited. We examined durability of mumps antibody response among adults up to 11 years after receipt of MMR3. METHODS: Persons who received MMR3 at ages 18-28 years had sera collected before (baseline), 1 month,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Neutralizing
Share to Antibodies, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antibody Affinity

Share to Immunization, Secondary

Share to Immunoglobulin G

Share to Mumps virus

Share to Young Adult

Source

Identifiers

PMID: 41358808
DOI: 10.1093/infdis/jiaf520

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Durability of the Mumps Antibody Response After the Third Dose of MMR Vaccine.PMID 41358808Read ↗

Vaccine waning and mumps re-emergence in the United StatesSemantic proximity Read ↗

Seroprevalence of measles-specific IgG and genotype-specific neutralizing antibody responses in clinically confirmed cases during the 2021–2023 measles outbreaks in LiberiaSemantic proximity Read ↗

An efficient, reproducible and accurate RT-qPCR based method to determine mumps specific neutralizing antibody.Semantic proximity Read ↗

Virus genotypes and responses of serum-specific antibodies in children with primary mumps and mumps reinfection.Semantic proximity Read ↗

Heterogeneity and longevity of antibody memory to viruses and vaccinesSemantic proximity Read ↗

Mumps resurgence in a highly vaccinated population: Insights gained from surveillance in Canada, 2002–2020Semantic proximity Read ↗

Measles Vaccine Virus RNA in Children More Than 100 Days after VaccinationSemantic proximity Read ↗

Unveiling Rubella Antibody Trends of Healthy Populations in Guangzhou and Heyuan, Guangdong Province, China, 2021-2023Semantic proximity Read ↗

Immunogenicity of Mumps Virus Genotype G Vaccine Candidates in Jeryl Lynn-Immunized Mice.Semantic proximity Read ↗

Antibody Responses in Pediatric Dengue Indicate Emergence and Co-Circulation of DENV-3 Genotypes I and III in Myanmar and Orthoflavivirus Cross-Reactivity.Semantic proximity Read ↗

Mumps outbreaks in a highly vaccinated population: Investigation of a neutralization titre against the current circulating wildtype genotype G5 mumps virus.Semantic proximity Read ↗

Antibody Induced by Immunization with the Jeryl Lynn Mumps Vaccine Strain Effectively Neutralizes a Heterologous Wild‐Type Mumps Virus Associated with a Large OutbreakSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.